Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Fluoxetine versus placebo for the marijuana use of depressed alcoholics.

Cornelius JR, Salloum IM, Haskett RF, Ehler JG, Jarrett PJ, Thase ME, Perel JM.

Addict Behav. 1999 Jan-Feb;24(1):111-4.

PMID:
10189977
2.

Fluoxetine versus placebo in depressed alcoholic cocaine abusers.

Cornelius JR, Salloum IM, Thase ME, Haskett RF, Daley DC, Jones-Barlock A, Upsher C, Perel JM.

Psychopharmacol Bull. 1998;34(1):117-21.

PMID:
9564208
3.

Double-blind fluoxetine in depressed alcoholic smokers.

Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Black A, Perel JM, Thase ME.

Psychopharmacol Bull. 1997;33(1):165-70.

PMID:
9133770
4.

Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial.

Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Perel JM, Thase ME, Black A.

Arch Gen Psychiatry. 1997 Aug;54(8):700-5.

PMID:
9283504
5.

Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study.

Cornelius JR, Salloum IM, Haskett RF, Daley DC, Cornelius MD, Thase ME, Perel JM.

Addict Behav. 2000 Mar-Apr;25(2):307-10.

PMID:
10795957
6.

Preliminary report: double-blind, placebo-controlled study of fluoxetine in depressed alcoholics.

Cornelius JR, Salloum IM, Cornelius MD, Perel JM, Ehler JG, Jarrett PJ, Levin RL, Black A, Mann JJ.

Psychopharmacol Bull. 1995;31(2):297-303.

PMID:
7491382
7.

Treating the substance-abusing suicidal patient.

Cornelius JR, Salloum IM, Lynch K, Clark DB, Mann JJ.

Ann N Y Acad Sci. 2001 Apr;932:78-90; discussion 91-3.

PMID:
11411192
8.

Fluoxetine versus placebo to decrease the smoking of depressed alcoholic patients.

Cornelius JR, Perkins KA, Salloum IM, Thase ME, Moss HB.

J Clin Psychopharmacol. 1999 Apr;19(2):183-4. No abstract available.

PMID:
10211921
9.

A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease.

Petracca GM, Chemerinski E, Starkstein SE.

Int Psychogeriatr. 2001 Jun;13(2):233-40.

PMID:
11495397
10.

Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression: a randomized double-blind trial in a Brazilian sample.

Moreno RA, Teng CT, Almeida KM, Tavares Junior H.

Rev Bras Psiquiatr. 2006 Mar;28(1):29-32. Epub 2006 Mar 24.

11.

Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial.

Cornelius JR, Bukstein OG, Birmaher B, Salloum IM, Lynch K, Pollock NK, Gershon S, Clark D.

Addict Behav. 2001 Sep-Oct;26(5):735-9.

PMID:
11676382
12.

A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.

Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF.

J Clin Psychopharmacol. 2005 Oct;25(5):441-7.

PMID:
16160619
13.

A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.

Nemeroff CB, Thase ME; EPIC 014 Study Group.

J Psychiatr Res. 2007 Apr-Jun;41(3-4):351-9. Epub 2005 Sep 12.

PMID:
16165158
14.
15.

Fluoxetine in the prevention of depressive recurrences: a double-blind study.

Gilaberte I, Montejo AL, de la Gandara J, Perez-Sola V, Bernardo M, Massana J, Martin-Santos R, Santiso A, Noguera R, Casais L, Perez-Camo V, Arias M, Judge R; Fluoxetine Long-Term Study Group.

J Clin Psychopharmacol. 2001 Aug;21(4):417-24.

PMID:
11476126
16.
17.

Fluoxetine trial in suicidal depressed alcoholics.

Cornelius JR, Salloum IM, Cornelius MD, Perel JM, Thase ME, Ehler JG, Mann JJ.

Psychopharmacol Bull. 1993;29(2):195-9.

PMID:
8290665
18.

Patient characteristics and treatment implications of marijuana abuse among bipolar alcoholics: results from a double blind, placebo-controlled study.

Salloum IM, Cornelius JR, Douaihy A, Kirisci L, Daley DC, Kelly TM.

Addict Behav. 2005 Oct;30(9):1702-8. Epub 2005 Aug 11.

PMID:
16098680
20.

Supplemental Content

Support Center